Advanced
  Home Compare Reports

Comparison with Similar Reports

Compression Therapy Market by Technique (Static, Dynamic), Product (Garments (Stockings, Bandages, Wraps), Ortho Braces, Pump), Application (Varicose ...

Publisher:       

# of Pages:        217

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED FOR THE STUDY 31
1.4 CURRENCY USED FOR THE STUDY 31
TABLE 1 STANDARD CURRENCY CONVERSION RATES 32
1.5 LIMITATIONS 32
1.6 MARKET STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY RESEARCH 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 38
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 39
2.2 MARKET ESTIMATION METHODOLOGY 40
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 40
2.2.2 SALES/DISTRIBUTION CHANNEL-BASED MARKET ESTIMATION 41
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL COMPRESSION THERAPY MARKET 42
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 43
2.2.3 PRIMARY RESEARCH VALIDATION 43
2.3 COVID-19 HEALTH ASSESSMENT 43
2.4 COVID-19 ECONOMIC ASSESSMENT 43
2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 44
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 44
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 45
2.6 DATA TRIANGULATION 46
FIGURE 8 DATA TRIANGULATION 46
2.7 RESEARCH ASSUMPTIONS 47
2.8 RESEARCH LIMITATIONS 47
3 EXECUTIVE SUMMARY 48
FIGURE 9 COMPRESSION THERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 48
FIGURE 10 COMPRESSION THERAPY MARKET SHARE, BY TECHNIQUE, 2021 VS. 2026 49
FIGURE 11 COMPRESSION THERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 49
FIGURE 12 COMPRESSION THERAPY MARKET SHARE, BY DISTRIBUTION CHANNEL, 2021 VS. 2026 50
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE COMPRESSION THERAPY MARKET 50
4 PREMIUM INSIGHTS 52
4.1 COMPRESSION THERAPY MARKET OVERVIEW 52
4.2 COMPRESSION THERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 53
FIGURE 14 COMPRESSION PUMPS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 53
4.3 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2021 VS. 2026 (USD MILLION) 53
FIGURE 15 DYNAMIC COMPRESSION THERAPY SEGMENT TO WITNESS THE HIGHEST GROWTH FROM 2021 TO 2026 53
4.4 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021 VS. 2026 (USD MILLION) 54
FIGURE 16 PHARMACIES & RETAILERS SEGMENT TO DOMINATE THE COMPRESSION THERAPY MARKET IN 2026 54
4.5 COMPRESSION THERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 17 ASIA PACIFIC IS A LUCRATIVE MARKET FOR THE MANUFACTURERS OF COMPRESSION THERAPY PRODUCTS 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 18 COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Presence of a large target patient population 56
FIGURE 19 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 57
5.2.1.2 Increasing incidence of sports injuries and accidents 57
FIGURE 20 EUROPE: NUMBER OF ROAD ACCIDENTS, BY COUNTRY, 2016 58
5.2.1.3 Increasing number of orthopedic procedures 58
5.2.1.4 Greater product affordability and market availability 59
5.2.1.5 Clinical evidence favoring the adoption of compression therapy in the management of target conditions 59
5.2.2 RESTRAINTS 59
5.2.2.1 Lack of universally accepted standards for compression products 59
5.2.2.2 Low patient compliance for compression garments 60
FIGURE 21 REASONS FOR NON-COMPLIANCE TO COMPRESSION THERAPY 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth potential offered by emerging markets 61
5.2.3.2 Rising patient awareness regarding the benefits of compression therapy in target disease management 61
5.2.3.3 Increased sales of off-the-shelf and online products 62
5.2.4 CHALLENGES 62
5.2.4.1 Significant adoption of alternative therapies for specific target indications 62
5.2.4.2 Increasing pricing pressure on market players 62
5.3 COVID-19 IMPACT TRENDS 63
5.4 PORTER’S FIVE FORCES 64
5.4.1 OVERVIEW 64
TABLE 2 COMPRESSION THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS 64
5.4.2 BARGAINING POWER OF BUYERS 64
5.4.3 BARGAINING POWER OF SUPPLIERS 64
5.4.4 THREAT OF NEW ENTRANTS 65
5.4.5 THREAT OF SUBSTITUTES 65
5.4.6 INTENSITY OF COMPETITIVE RIVALRY 65
5.5 PRICING TREND ANALYSIS 65
TABLE 3 REGIONAL PRICING ANALYSIS OF KEY COMPRESSION THERAPY PRODUCTS, 2020 (USD) 65
5.6 REGULATORY ANALYSIS 66
5.6.1 NORTH AMERICA 66
5.6.1.1 US 66
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 67
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 67
5.6.1.2 Canada 68
TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 68
FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 69
5.6.2 EUROPE 70
FIGURE 23 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 71
5.6.3 ASIA PACIFIC 72
5.6.3.1 Japan 72
TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 72
5.6.3.2 China 73
TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES 73
5.6.3.3 India 74
5.7 REIMBURSEMENT SCENARIO 75
TABLE 9 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES AS OF 2021 75
5.8 VALUE CHAIN ANALYSIS 77
FIGURE 24 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING THE MANUFACTURING PHASE 78
5.9 SUPPLY CHAIN ANALYSIS 78
5.9.1 PROMINENT COMPANIES 78
5.9.2 SMALL & MEDIUM-SIZED ENTERPRISES 78
5.9.3 END USERS 79
FIGURE 25 SUPPLY CHAIN ANALYSIS 79
5.10 ECOSYSTEM LANDSCAPE 79
5.10.1 PARENT MARKET: ORTHOPEDIC IMPLANTS, SURGICAL DEVICES, AND SUPPORT PRODUCTS 79
5.11 PATENT ANALYSIS 80
FIGURE 26 PATENT ANALYSIS 80
6 COMPRESSION THERAPY MARKET, BY TECHNIQUE 81
6.1 INTRODUCTION 82
TABLE 10 COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 82
6.2 STATIC COMPRESSION THERAPY 82
6.2.1 STATIC COMPRESSION THERAPY PROVIDES PROCEDURAL ADVANTAGES IN DISEASE MANAGEMENT 82
TABLE 11 STATIC COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 83
6.3 DYNAMIC COMPRESSION THERAPY 83
6.3.1 RISING INCIDENCE OF TARGET CONDITIONS IS A KEY FACTOR DRIVING MARKET GROWTH 83
TABLE 12 DYNAMIC COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 84
7 COMPRESSION THERAPY MARKET, BY PRODUCT 85
7.1 INTRODUCTION 86
TABLE 13 COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 86
7.2 COMPRESSION GARMENTS 86
TABLE 14 COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 86
TABLE 15 COMPRESSION GARMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 87
7.2.1 COMPRESSION GARMENTS MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION) 87
TABLE 16 COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 87
7.2.2 COMPRESSION GARMENTS MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION) 87
TABLE 17 COMPRESSION GARMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 87
7.2.3 COMPRESSION GARMENTS MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 88
TABLE 18 COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 88
7.2.3.1 Compression bandages & wraps 88
7.2.3.1.1 Limited availability of medical reimbursements for varicose vein surgeries to restrain the market growth 88
TABLE 19 COMPRESSION BANDAGES & WRAPS MARKET, BY REGION, 2019–2026 (USD MILLION) 89
7.2.3.1.2 Compression bandages & wraps market split, by technique, 2019–2026 (USD million) 89
TABLE 20 COMPRESSION BANDAGES & WRAPS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 89
7.2.3.1.3 Compression bandages & wraps market split, by application, 2019–2026 (USD Million) 90
TABLE 21 COMPRESSION BANDAGES & WRAPS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 90
7.2.3.1.4 Compression bandages & wraps market split, by distribution channel, 2019–2026 (USD Million) 90
TABLE 22 COMPRESSION BANDAGES & WRAPS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 90
7.2.3.2 Compression stockings 90
7.2.3.2.1 Use of compression stockings in the long-term management of venous diseases to support market growth 90
TABLE 23 COMPRESSION STOCKINGS MARKET, BY REGION, 2019–2026 (USD MILLION) 91
7.2.3.2.2 Compression stockings market split, by technique, 2019–2026 (USD Million) 92
TABLE 24 COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 92
7.2.3.2.3 Compression stockings market split, by application, 2019–2026 (USD Million) 92
TABLE 25 COMPRESSION STOCKINGS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 92
7.2.3.2.4 Compression stockings market split, by distribution channel, 2019–2026 (USD Million) 93
TABLE 26 COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 93
7.2.3.3 Other compression garments 93
TABLE 27 OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 93
7.2.3.3.1 Other compression garments market split, by technique, 2019–2026 (USD Million) 94
TABLE 28 OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 94
7.2.3.3.2 Other compression garments market split, by application, 2019–2026 (USD Million) 94
TABLE 29 OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 94
7.2.3.3.3 Other compression garments market split, by distribution channel, 2019–2026 (USD Million) 95
TABLE 30 OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 95
7.3 COMPRESSION PUMPS 95
7.3.1 RISING PREVALENCE OF CHRONIC VENOUS DISEASES TO DRIVE MARKET GROWTH 95
TABLE 31 COMPRESSION PUMPS MARKET, BY REGION, 2019–2026 (USD MILLION) 96
7.3.2 COMPRESSION PUMPS MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION) 96
TABLE 32 COMPRESSION PUMPS MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 96
7.3.3 COMPRESSION PUMPS MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION) 97
TABLE 33 COMPRESSION PUMPS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 97
7.3.4 COMPRESSION PUMPS MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 97
TABLE 34 COMPRESSION PUMPS MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 97
7.4 COMPRESSION BRACES 98
7.4.1 RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET GROWTH 98
TABLE 35 COMPRESSION BRACES MARKET, BY REGION, 2019–2026 (USD MILLION) 98
7.4.2 COMPRESSION BRACES MARKET SPLIT, BY TECHNIQUE, 2019–2026 (USD MILLION) 98
TABLE 36 COMPRESSION BRACES MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 98
7.4.3 COMPRESSION BRACES MARKET SPLIT, BY APPLICATION, 2019–2026 (USD MILLION) 99
TABLE 37 COMPRESSION BRACES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 99
7.4.4 COMPRESSION BRACES MARKET SPLIT, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 99
TABLE 38 COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 99
8 COMPRESSION THERAPY MARKET, BY APPLICATION 100
8.1 INTRODUCTION 101
TABLE 39 COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
8.2 VARICOSE VEIN TREATMENT 101
8.2.1 COMPRESSION THERAPY IS CONSIDERED AS THE FIRST LINE OF TREATMENT FOR VARICOSE VEINS 101
TABLE 40 COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2019–2026 (USD MILLION) 102
8.3 DEEP VEIN THROMBOSIS TREATMENT 102
8.3.1 AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT MARKET GROWTH 102
TABLE 41 COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT, BY REGION, 2019–2026 (USD MILLION) 103
8.4 LYMPHEDEMA TREATMENT 103
8.4.1 RISING INCIDENCE OF CANCER TO SUPPORT MARKET GROWTH 103
TABLE 42 COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2019–2026 (USD MILLION) 104
8.5 LEG ULCER TREATMENT 104
8.5.1 GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO SUPPORT MARKET GROWTH 104
TABLE 43 COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2019–2026 (USD MILLION) 105
8.6 OTHER APPLICATIONS 106
TABLE 44 COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 106
9 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL 107
9.1 INTRODUCTION 108
TABLE 45 COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 108
9.2 PHARMACIES & RETAILERS 108
9.2.1 RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH 108
TABLE 46 COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2019–2026 (USD MILLION) 109
9.3 E-COMMERCE PLATFORMS 109
9.3.1 E-COMMERCE PLATFORMS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 109
TABLE 47 COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2019–2026 (USD MILLION) 110
9.4 HOSPITALS & CLINICS 110
9.4.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO SUPPORT MARKET GROWTH 110
TABLE 48 COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2026 (USD MILLION) 110
10 COMPRESSION THERAPY MARKET, BY REGION 111
10.1 INTRODUCTION 112
TABLE 49 COMPRESSION THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION) 112
10.2 NORTH AMERICA 112
FIGURE 27 NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT 113
TABLE 50 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 51 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 114
TABLE 52 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 114
TABLE 53 NORTH AMERICA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 115
TABLE 54 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 115
TABLE 55 NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 116
10.2.1 US 116
10.2.1.1 Rising number of sports injuries to drive market growth 116
TABLE 56 US: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 117
TABLE 57 US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 117
TABLE 58 US: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 118
TABLE 59 US: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 118
10.2.2 CANADA 118
10.2.2.1 Increasing incidence of target diseases is the major factor supporting market growth in Canada 118
TABLE 60 CANADA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 119
TABLE 61 CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 120
TABLE 62 CANADA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 120
TABLE 63 CANADA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 120
10.3 EUROPE 121
TABLE 64 EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 65 EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 122
TABLE 66 EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 122
TABLE 67 EUROPE: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 122
TABLE 68 EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
TABLE 69 EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 123
10.3.1 GERMANY 123
10.3.1.1 Inconsistent reimbursement for compression therapy products to restrain market growth to a certain extent in Germany 123
TABLE 70 GERMANY: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 124
TABLE 71 GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 124
TABLE 72 GERMANY: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 125
TABLE 73 GERMANY: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 125
10.3.2 UK 125
10.3.2.1 Rising prevalence of lymphedema and DVT to drive market growth 125
TABLE 74 UK: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 126
TABLE 75 UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 126
TABLE 76 UK: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 127
TABLE 77 UK: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 127
10.3.3 FRANCE 127
10.3.3.1 Increasing incidence of target indications will increase the demand for compression therapy 127
TABLE 78 FRANCE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 128
TABLE 79 FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 128
TABLE 80 FRANCE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 129
TABLE 81 FRANCE COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 129
10.3.4 ITALY 129
10.3.4.1 Rising awareness about preventive care for musculoskeletal injuries to support market growth 129
TABLE 82 ITALY: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 130
TABLE 83 ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 130
TABLE 84 ITALY: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 130
TABLE 85 ITALY: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 131
10.3.5 SPAIN 131
10.3.5.1 Rising prevalence of target diseases to support market growth in Spain 131
TABLE 86 SPAIN: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 131
TABLE 87 SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 132
TABLE 88 SPAIN: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
TABLE 89 SPAIN: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 132
10.3.6 REST OF EUROPE 133
TABLE 90 ROE: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 133
TABLE 91 ROE: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 134
TABLE 92 ROE: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 134
TABLE 93 ROE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 134
10.4 ASIA PACIFIC 135
FIGURE 28 ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT 136
TABLE 94 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 137
TABLE 95 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 137
TABLE 96 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 137
TABLE 97 ASIA PACIFIC COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 98 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 138
TABLE 99 ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 138
10.4.1 JAPAN 139
10.4.1.1 Japan dominates the APAC compression therapy market 139
TABLE 100 JAPAN: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 139
TABLE 101 JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 140
TABLE 102 JAPAN: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 140
TABLE 103 JAPAN: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 140
10.4.2 CHINA 141
10.4.2.1 Expansion of the target patient population and modernization of healthcare facilities to drive market growth in China 141
TABLE 104 CHINA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 141
TABLE 105 CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 142
TABLE 106 CHINA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 142
TABLE 107 CHINA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 142
10.4.3 INDIA 143
10.4.3.1 Growing number of hip & knee surgeries to support market growth 143
TABLE 108 INDIA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 143
TABLE 109 INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 144
TABLE 110 INDIA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 144
TABLE 111 INDIA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 144
10.4.4 AUSTRALIA 145
10.4.4.1 Government subsidies for purchasing compression garments for lymphedema patients to support market growth 145
TABLE 112 AUSTRALIA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 145
TABLE 113 AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 146
TABLE 114 AUSTRALIA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 146
TABLE 115 AUSTRALIA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 146
10.4.5 SOUTH KOREA 147
10.4.5.1 Increasing number of plastic surgeries in the country to drive the demand for compression garments 147
TABLE 116 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 147
TABLE 117 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 147
TABLE 118 SOUTH KOREA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 148
TABLE 119 SOUTH KOREA COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 149
10.4.6 REST OF ASIA PACIFIC 149
TABLE 120 ROAPAC: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 149
TABLE 121 ROAPAC: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 150
TABLE 122 ROAPAC: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 150
TABLE 123 ROAPAC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 150
10.4.7 LATIN AMERICA 151
TABLE 124 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 125 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 151
TABLE 126 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 152
TABLE 127 LATIN AMERICA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 152
TABLE 128 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 153
TABLE 129 LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 153
10.4.7.1 Brazil 153
10.4.7.1.1 Rising number of cosmetic surgeries to support market growth in Brazil 153
TABLE 130 BRAZIL: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 154
TABLE 131 BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 154
TABLE 132 BRAZIL: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 155
TABLE 133 BRAZIL: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 155
10.4.7.2 Mexico 155
10.4.7.2.1 Rising prevalence of target diseases to support market growth in Mexico 155
TABLE 134 MEXICO: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 156
TABLE 135 MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 156
TABLE 136 MEXICO: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 157
TABLE 137 MEXICO: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 157
10.4.7.3 Rest of Latin America 157
TABLE 138 ROLATAM: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 158
TABLE 139 ROLATAM: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 158
TABLE 140 ROLATAM: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 158
TABLE 141 ROLATAM: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 159
10.4.8 MIDDLE EAST & AFRICA 159
10.4.8.1 Unfavorable reimbursement scenario to hamper the market growth in the MEA 159
TABLE 142 MEA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2019–2026 (USD MILLION) 159
TABLE 143 MEA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 160
TABLE 144 MEA: COMPRESSION GARMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 145 MEA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 160
TABLE 146 MEA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2019–2026 (USD MILLION) 161
11 COMPETITIVE LANDSCAPE 162
11.1 OVERVIEW 162
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 162
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE COMPRESSION THERAPY MARKET 162
TABLE 147 STRATEGIES ADOPTED BY KEY COMPRESSION THERAPY PRODUCT MANUFACTURING COMPANIES 162
11.3 REVENUE SHARE ANALYSIS 163
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE COMPRESSION THERAPY MARKET 163
11.4 MARKET SHARE ANALYSIS 164
FIGURE 30 COMPRESSION THERAPY MARKET SHARE, BY KEY PLAYER, 2020 164
11.5 COMPETITIVE SITUATIONS AND TRENDS 165
TABLE 148 COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION 165
11.6 COMPANY EVALUATION QUADRANT 165
11.7 COMPETITIVE LEADERSHIP MAPPING 165
11.7.1 STARS 166
11.7.2 EMERGING LEADERS 166
11.7.3 PERVASIVE PLAYERS 166
11.7.4 PARTICIPANTS 166
FIGURE 31 COMPRESSION THERAPY MARKET (GLOBAL): COMPANY EVALUATION MATRIX, 2020 167
11.8 COMPETITIVE EVALUATION QUADRANT FOR SMES/START-UPS 168
11.8.1 PROGRESSIVE COMPANIES 168
11.8.2 STARTING BLOCKS 168
11.8.3 RESPONSIVE COMPANIES 168
11.8.4 DYNAMIC COMPANIES 168
FIGURE 32 COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2020 169
11.9 COMPETITIVE BENCHMARKING 170
FIGURE 33 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE COMPRESSION THERAPY MARKET 170
TABLE 149 COMPANY PRODUCT FOOTPRINT 170
TABLE 150 COMPANY GEOGRAPHICAL FOOTPRINT 171
11.10 COMPETITIVE SCENARIO 171
TABLE 151 PRODUCT LAUNCHES & ENHANCEMENTS 171
TABLE 152 DEALS 172
12 COMPANY PROFILES 173
12.1 KEY PLAYERS 173
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win,
Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 3M 173
TABLE 153 3M: BUSINESS OVERVIEW 173
FIGURE 34 3M: COMPANY SNAPSHOT (2020) 174
12.1.2 ARJOHUNTLEIGH 177
TABLE 154 ARJOHUNTLEIGH: BUSINESS OVERVIEW 177
FIGURE 35 ARJOHUNTLEIGH: COMPANY SNAPSHOT (2020) 177
12.1.3 BIO COMPRESSION SYSTEMS, INC. 179
TABLE 155 BIO COMPRESSION SYSTEMS, INC.: BUSINESS OVERVIEW 179
12.1.4 BSN MEDICAL 180
TABLE 156 ESSITY: BUSINESS OVERVIEW 180
FIGURE 36 ESSITY: COMPANY SNAPSHOT (2020) 181
12.1.5 CARDINAL HEALTH 184
TABLE 157 CARDINAL HEALTH: BUSINESS OVERVIEW 184
FIGURE 37 CARDINAL HEALTH: COMPANY SNAPSHOT (2020) 185
12.1.6 CONVATEC INC. 187
TABLE 158 CONVATEC INC.: BUSINESS OVERVIEW 187
FIGURE 38 CONVATEC INC.: COMPANY SNAPSHOT (2020) 188
12.1.7 DJO, INC. (A SUBSIDIARY OF COLFAX CORPORATION) 190
TABLE 159 DJO, INC.: BUSINESS OVERVIEW 190
FIGURE 39 COLFAX CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.8 JULIUS ZORN GMBH 193
TABLE 160 JULIUS ZORN GMBH: BUSINESS OVERVIEW 193
12.1.9 MEDI GMBH & CO. KG 195
TABLE 161 MEDI GMBH & CO. KG: BUSINESS OVERVIEW 195
12.1.10 PAUL HARTMANN AG 197
TABLE 162 PAUL HARTMANN AG: BUSINESS OVERVIEW 197
FIGURE 40 PAUL HARTMANN AG: COMPANY SNAPSHOT (2020) 198
12.1.11 SANYLEG S.R.L. 200
TABLE 163 SANYLEG S.R.L.: BUSINESS OVERVIEW 200
12.1.12 SIGVARIS GROUP 203
TABLE 164 SIGVARIS GROUP: BUSINESS OVERVIEW 203
12.1.13 SMITH & NEPHEW PLC 205
TABLE 165 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 205
FIGURE 41 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020) 206
12.1.14 TACTILE MEDICAL 208
TABLE 166 TACTILE MEDICAL: BUSINESS OVERVIEW 208
FIGURE 42 TACTILE MEDICAL: COMPANY SNAPSHOT (2020) 208
12.2 OTHER PLAYERS 210
12.2.1 GOTTFRIED MEDICAL, INC. 210
TABLE 167 GOTTFRIED MEDICAL, INC.: BUSINESS OVERVIEW 210
12.2.2 THERMOTEK, INC. 211
TABLE 168 THERMOTEK, INC.: BUSINESS OVERVIEW 211
12.2.3 BAUERFEIND AG 213
TABLE 169 BAUERFEIND AG: BUSINESS OVERVIEW 213
12.2.4 OFA BAMBERG GMBH 215
TABLE 170 OFA BAMBERG GMBH: BUSINESS OVERVIEW 215
12.2.5 ACI MEDICAL, LLC 216
TABLE 171 ACI MEDICAL, LLC: BUSINESS OVERVIEW 216
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 217
13.1 DISCUSSION GUIDE 217
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 221
13.3 AVAILABLE CUSTOMIZATIONS 223
13.4 RELATED REPORTS 223
13.5 AUTHOR DETAILS 224

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127